相似文献
1
ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCE.
J Exp Med. 1931 Jan 1;53(1):93-107. doi: 10.1084/jem.53.1.93.
2
PROPERTIES OF THE TYPE SPECIFIC PROTEINS OF ANTIPNEUMOCOCCUS SERA : II. IMMUNOLOGICAL FRACTIONATION OF TYPE I ANTIPNEUMOCOCCUS HORSE AND RABBIT SERA.
J Exp Med. 1937 Sep 30;66(4):425-35. doi: 10.1084/jem.66.4.425.
3
A STUDY OF PNEUMOCOCCI REACTING WITH ANTIPNEUMOCOCCUS SERA OF TYPES I, II, AND III, WITH AN OBSERVATION OF A MUTATION OF ONE OF THE STRAINS.
J Exp Med. 1919 Aug 1;30(2):123-46. doi: 10.1084/jem.30.2.123.
4
THE IMMUNOLOGICAL RELATIONSHIP OF THE CAPSULAR POLYSACCHARIDE OF TYPE XIV PNEUMOCOCCUS TO THE BLOOD GROUP A SPECIFIC SUBSTANCE.
J Exp Med. 1939 Aug 31;70(3):239-47. doi: 10.1084/jem.70.3.239.
5
THE ANTIPNEUMOCOCCUS PROPERTIES OF NORMAL SWINE SERUM.
J Exp Med. 1932 May 31;55(6):877-88. doi: 10.1084/jem.55.6.877.
6
AN EXAMINATION OF THE MECHANISM OF PNEUMOCOCCUS IMMUNITY BY MEANS OF BACTERICIDAL MEASUREMENTS : I. THE REACTION BETWEEN THE ANTICARBOHYDRATE ANTIBODY AND THE PURIFIED SPECIFIC CARBOHYDRATE.
J Exp Med. 1932 Mar 31;55(4):511-8. doi: 10.1084/jem.55.4.511.
7
THE PROTECTIVE ACTION OF TYPE I ANTIPNEUMOCOCCUS SERUM IN MICE : IV. THE PROZONE.
J Exp Med. 1936 Aug 31;64(3):369-75. doi: 10.1084/jem.64.3.369.
8
PROPERTIES OF THE TYPE SPECIFIC PROTEINS OF ANTIPNEUMOCOCCUS SERA : I. THE MOUSE PROTECTIVE VALUE OF TYPE I SERA WITH REFERENCE TO THE PRECIPITIN CONTENT.
J Exp Med. 1937 Sep 30;66(4):413-24. doi: 10.1084/jem.66.4.413.
9
QUANTITATIVE EXPERIMENTS WITH ANTIBODIES TO A SPECIFIC PRECIPITATE. I.
J Exp Med. 1941 Jan 1;73(1):125-40. doi: 10.1084/jem.73.1.125.
10
THE CONCENTRATION OF THE PROTECTIVE BODIES IN ANTIPNEUMOCOCCUS SERUM. SPECIFIC PRECIPITATE EXTRACTS.
J Exp Med. 1915 Aug 1;22(2):248-68. doi: 10.1084/jem.22.2.248.
引用本文的文献
1
THE IMMUNOLOGICAL RELATIONSHIP OF THE CAPSULAR POLYSACCHARIDE OF TYPE XIV PNEUMOCOCCUS TO THE BLOOD GROUP A SPECIFIC SUBSTANCE.
J Exp Med. 1939 Aug 31;70(3):239-47. doi: 10.1084/jem.70.3.239.
2
ON THE USE OF ADSORBENTS IN IMMUNIZATIONS WITH HAPTENS.
J Exp Med. 1934 Mar 31;59(4):479-90. doi: 10.1084/jem.59.4.479.
3
CHEMOIMMUNOLOGICAL STUDIES ON THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : I. THE ISOLATION AND PROPERTIES OF THE ACETYL POLYSACCHARIDE OF PNEUMOCOCCUS TYPE I.
J Exp Med. 1933 Nov 30;58(6):731-55. doi: 10.1084/jem.58.6.731.
4
THE PRECIPITIN REACTION OF ANTIPNEUMOCOCCUS SERA : III. THE RATIO OF PRECIPITIN TO PROTECTIVE ANTIBODY IN TYPE II.
J Exp Med. 1931 Feb 28;53(3):299-301. doi: 10.1084/jem.53.3.299.
5
Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.
J Exp Med. 1984 Aug 1;160(2):386-97. doi: 10.1084/jem.160.2.386.
6
Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).
J Exp Med. 1987 Feb 1;165(2):381-94. doi: 10.1084/jem.165.2.381.
本文引用的文献
1
A TYPE SPECIFIC SUBSTANCE DISTINCT FROM THE SPECIFIC CARBOHYDRATE IN PNEUMOCOCCUS TYPE I.
J Exp Med. 1930 Jul 31;52(2):235-52. doi: 10.1084/jem.52.2.235.
2
A QUANTITATIVE STUDY OF THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND PURIFIED HOMOLOGOUS ANTIBODY.
J Exp Med. 1929 Nov 30;50(6):809-23. doi: 10.1084/jem.50.6.809.
3
IMMUNOLOGICAL PROPERTIES OF A TYPICAL (S-PRODUCING) AND A DEGRADED (NON-S-PRODUCING) STRAIN OF TYPE II PNEUMOCOCCUS WITH SPECIAL REFERENCE TO PROTECTIVE ANTIBODIES.
J Exp Med. 1927 Jun 30;46(1):101-11. doi: 10.1084/jem.46.1.101.
4
STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VI. THE SPECIFIC EFFECT OF PNEUMOCOCCUS SOLUBLE SUBSTANCE ON THE GROWTH OF PNEUMOCOCCI IN NORMAL SERUM-LEUCOCYTE MIXTURES.
J Exp Med. 1926 Apr 30;43(5):633-45. doi: 10.1084/jem.43.5.633.
5
THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : THIRD PAPER.
J Exp Med. 1925 Oct 31;42(5):727-45. doi: 10.1084/jem.42.5.727.
6
THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.
J Exp Med. 1917 Oct 1;26(4):477-93. doi: 10.1084/jem.26.4.477.
7
THE NEUTRALIZATION OF ANTIPNEUMOCOCCUS IMMUNE BODIES BY INFECTED EXUDATES AND SERA.
J Exp Med. 1917 Oct 1;26(4):453-75. doi: 10.1084/jem.26.4.453.
8
CONCENTRATION OF THE PROTECTIVE BODIES IN ANTIPNEUMOCOCCUS SERUM BY MEANS OF SPECIFIC PRECIPITATION.
J Exp Med. 1915 Apr 1;21(4):389-400. doi: 10.1084/jem.21.4.389.
Zotero 插件